BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20465434)

  • 1. Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study.
    Sofi F; Giangrandi I; Cesari F; Corsani I; Abbate R; Gensini GF; Casini A
    Int J Food Sci Nutr; 2010 Dec; 61(8):792-802. PubMed ID: 20465434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids].
    Rodríguez-Cruz M; Tovar AR; del Prado M; Torres N
    Rev Invest Clin; 2005; 57(3):457-72. PubMed ID: 16187707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.
    Capanni M; Calella F; Biagini MR; Genise S; Raimondi L; Bedogni G; Svegliati-Baroni G; Sofi F; Milani S; Abbate R; Surrenti C; Casini A
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1143-51. PubMed ID: 16611275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease.
    Masterton GS; Plevris JN; Hayes PC
    Aliment Pharmacol Ther; 2010 Apr; 31(7):679-92. PubMed ID: 20415840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of novel foods enriched with long-chain n-3 fatty acids to increase dietary intake: a comparison of methodologies assessing nutrient intake.
    Patch CS; Tapsell LC; Mori TA; Meyer BJ; Murphy KJ; Mansour J; Noakes M; Clifton PM; Puddey IB; Beilin LJ; Annison G; Howe PR
    J Am Diet Assoc; 2005 Dec; 105(12):1918-26. PubMed ID: 16321598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acids: a specific liver drug for non-alcoholic fatty liver disease (NAFLD).
    Xin YN; Xuan SY; Zhang JH; Zheng MH; Guan HS
    Med Hypotheses; 2008 Nov; 71(5):820-1. PubMed ID: 18752901
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil.
    Brunborg LA; Madland TM; Lind RA; Arslan G; Berstad A; Frøyland L
    Clin Nutr; 2008 Aug; 27(4):614-22. PubMed ID: 18374458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fatty acid and element changes after partial hepatectomy in mice fed olive oil- and corn oil-enriched diets.
    Domitrovic R; Milin C; Radosevic-Stasic B
    Biol Trace Elem Res; 2006 Jan; 109(1):61-74. PubMed ID: 16388104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease.
    Elizondo A; Araya J; Rodrigo R; Signorini C; Sgherri C; Comporti M; Poniachik J; Videla LA
    Biol Res; 2008; 41(1):59-68. PubMed ID: 18769764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with omega-3 fatty acids but not exendin-4 improves hepatic steatosis.
    Bulchandani DG; Nachnani JS; Nookala A; Naumovitch C; Herndon B; Molteni A; Quinn T; Alba LM
    Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1245-52. PubMed ID: 20651599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats.
    Zeghichi-Hamri S; de Lorgeril M; Salen P; Chibane M; de Leiris J; Boucher F; Laporte F
    Nutr Res; 2010 Dec; 30(12):849-57. PubMed ID: 21147368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical approach to increasing intakes of n-3 polyunsaturated fatty acids: use of novel foods enriched with n-3 fats.
    Metcalf RG; James MJ; Mantzioris E; Cleland LG
    Eur J Clin Nutr; 2003 Dec; 57(12):1605-12. PubMed ID: 14647226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marine lipids: overview "news insights and lipid composition of Lyprinol".
    Sinclair AJ; Murphy KJ; Li D
    Allerg Immunol (Paris); 2000 Sep; 32(7):261-71. PubMed ID: 11094639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary sources of omega 3 fatty acids: public health risks and benefits.
    Tur JA; Bibiloni MM; Sureda A; Pons A
    Br J Nutr; 2012 Jun; 107 Suppl 2():S23-52. PubMed ID: 22591897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
    Dyerberg J; Eskesen DC; Andersen PW; Astrup A; Buemann B; Christensen JH; Clausen P; Rasmussen BF; Schmidt EB; Tholstrup T; Toft E; Toubro S; Stender S
    Eur J Clin Nutr; 2004 Jul; 58(7):1062-70. PubMed ID: 15220949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
    Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
    Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease.
    Shapiro H; Tehilla M; Attal-Singer J; Bruck R; Luzzatti R; Singer P
    Clin Nutr; 2011 Feb; 30(1):6-19. PubMed ID: 20619513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture.
    Caramia G; Cocchi M; Gagliardini R; Malavolta M; Mozzon M; Frega NG
    Pediatr Med Chir; 2003; 25(1):42-9. PubMed ID: 12920976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
    Allard JP; Aghdassi E; Mohammed S; Raman M; Avand G; Arendt BM; Jalali P; Kandasamy T; Prayitno N; Sherman M; Guindi M; Ma DW; Heathcote JE
    J Hepatol; 2008 Feb; 48(2):300-7. PubMed ID: 18086506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.